Purification and antioxidant activities of soybean isoflavones by Wu, Qiju
Louisiana State University
LSU Digital Commons
LSU Master's Theses Graduate School
2003
Purification and antioxidant activities of soybean
isoflavones
Qiju Wu
Louisiana State University and Agricultural and Mechanical College
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_theses
Part of the Life Sciences Commons
This Thesis is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU
Master's Theses by an authorized graduate school editor of LSU Digital Commons. For more information, please contact gradetd@lsu.edu.
Recommended Citation
Wu, Qiju, "Purification and antioxidant activities of soybean isoflavones" (2003). LSU Master's Theses. 354.
https://digitalcommons.lsu.edu/gradschool_theses/354
      
 
 
PURIFICATION AND ANTIOXIDANT ACTIVITIES OF 
SOYBEAN ISOFLAVONES 
 
 
 
A Thesis  
 
 
 
 
Submitted to the Graduate Faculty of the 
Louisiana State University and 
Agricultural and Mechanical College 
in partial fulfillment of the 
requirements for the degree of  
Master of Science 
 
 
in 
 
 
The Department of Food Science 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
by 
Qiju Wu 
B.S., Zhejiang University, 1999 
August, 2003
  ii    
Acknowledgements 
 
            I want to begin by thanking my major professor, Dr. J. Samuel Godber, Professor 
in the Department of Food Science, for his patient guidance, precious advice, and 
persistent encouragement during the preparation and investigation of this thesis. 
            Special thanks to Dr. Zhimin Xu, Department of Food Science, he has been 
directly guiding my research since I came to LSU. Thank you for introducing me into the 
area of functional food and any patient instruction and help. Your profound insight into 
problems deeply impressed me. I would also like to express my most sincere appreciation 
to Dr. Jack N. Losso, Assistant Professor in the Department of Food Science, who has 
been giving me the most support and the best suggestions. Appreciation is extended to 
Dr. Grover L. Waldrop, Associate Professor in the Department of Biological Science, for 
his instruction and serving as a member of my committee and Dr. Vincent L. Wilson, 
Professor in the Department of Environmental Studies, for his precious time given to me 
to consult about the problems of my research. 
            I would like to show my deepest gratitude to my parents for their unconditional 
and unending love and my brothers and sisters for their persistent support. Without them, 
I would not have the chance to pursue the cutting edge education in US. Deep gratitude is 
also given to all my American friends for everything they have done to help me get used 
to the new culture, so I could start my knowledge absorbing life in US more quickly. 
            I also wish to thank all the professors and the friendly office staff of the Food 
Science Department at LSU, whose help with many issues was much appreciated. 
  iii    
Table of Contents 
 
 
List of Tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  v 
 
List of Figures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  vi 
 
 
Chapter 1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
 
Chapter 2 Overview of the Mechanisms for Soybean Isoflavones Health 
                  Improvement Actions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 
5 
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 
            2.2 Anticancer Actions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 
                    2.2.1 Cancer Preventive Function  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  5 
                    2.2.2 Cancer Inhibitory Function  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11 
2.3 Cardiovascular System Protective Actions  . . . . . . . . . . . . . . . . . . . . . . .  16 
            2.4 Anti-osteoporosis Actions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  19 
            2.5 Other Applications of Soybean Isoflavones . . . . . . . . . . . . . . . . . . . . . . .  20 
            2.6 Future Implications of Soybean Isoflavones . . . . . . . . . . . . . . . . . . . . . .  21 
 
Chapter 3 Materials and Methods  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  23 
            3.1 Extraction and Purification of Soybean Isoflavones   . . . . . . . . . . . . . . .  23 
                    3.1.1 Chemicals  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 
                    3.1.2 Extraction of Soybean Isoflavones . . . . . . . . . . . . . . . . . . . . . . . .  23 
                    3.1.3 Purification and Analysis of Daidzin, Glycitin, and Genistin  . . .  23 
            3.2 Antioxidant Activities of Soybean Isoflavones in Preventing 
                    Cholesterol Oxidation Accelerated by 2,2-Azobis(2- 
                    methylpropionamidine) Dihydrochloride. . . . . . . . . . . . . . . . . . . . . . . .  
 
 
24 
       3.2.1 Chemicals  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 
                    3.2.2 Cholesterol Oxidation System . . . . . . . . . . . . . . . . . . . . . . . . . . .  24 
                    3.2.3 Cholesterol Oxidation System Treatment with Soybean 
                               Isoflavones   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
25 
                    3.2.4 Statistical Analysis   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  26 
            3.3 Antioxidant Activities of Soybean Isoflavones on tert-Butyl 
                    Hydroperoxide-Induced Oxidative Stress in SVEC4-10 Cells  . . . . . . .  
 
26 
                    3.3.1 Chemicals  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 
                    3.3.2 Cell Culture and Cell Growth Curve . . . . . . . . . . . . . . . . . . . . . . . .  26 
                    3.3.3 Cytotoxicity Study of Genistein and Daidzein . . . . . . . . . . . . . . . .  27 
                    3.3.4 Cytotoxicity Study of tBOOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  28 
                    3.3.5 Cell Treatment with Soybean Isoflavones. . . . . . . . . . . . . . . . . . . .  28 
                    3.3.6 Statistical Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  29 
 
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ii 
Abstract . . . . . .. . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  vii 
  iv    
Chapter 4 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  30 
            4.1 Extraction and Purification of Soybean Isoflavones . . . . . . . . . . . . . . . .  30 
                    4.1.1 Purification and Analysis of Daidzin, Glycitin, and Genistin . . . .  30 
            4.2 Antioxidant Activities of Soybean Isoflavones in Preventing 
                    Cholesterol Oxidation Accelerated by 2,2-Azobis(2- 
                    methylpropionamidine) Dihydrochloride  . . . . . . . . . . . . . . . . . . . . . . .  
 
 
30 
                    4.2.1 Cholesterol Oxidation Products with AAPH Acceleration . . . . . .  30 
                    4.2.2 Antioxidant Activities of Genistein, Daidzein, and Glycosides 
                               Mixture from Defatted Soybean Flour  . . . . . . . . . . . . . . . . . . . .  
 
34 
            4.3 Antioxidant Activities of Soybean Isoflavones on tert-Butyl 
                    Hydroperoxide-Induced Oxidative Stress in SVEC4-10 Cells  . . . . . . .  
  
42 
                    4.3.1 Growth Curve of SVEC4-10 Cells  . . . . . . . . . . . . . . . . . . . . . . . .      42 
                    4.3.2 Cytotoxicity of Genistein and Daidzein  . . . . . . . . . . . . . . . . . . . .      43 
                    4.3.3 Cytotoxicity of tBOOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .     45 
                    4.3.4 Antioxidant Activities of Genistein and Daidzein  . . . . . . . . . . . .      46 
 
Chapter 5 Conclusion  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  50 
 
References . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  53 
 
Vita . . . . . . .  . . . . .. . . . . . . . . . . .. . . . . . . . . . . .. . . . . . . . . . . .. . . . . . . . . . . . . . .  61 
   
  v    
List of Tables 
 
 
Table 1. Concentration of each treatment in the reaction system in molar and 
mass unit  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
26 
   
Table 2. Comparison of percentages of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 
7-keto and 7β-OOH accelerated by AAPH with either 1 mM genistein 
or 1 mM daidzein treatment after 24 hr or 48 hr of reaction  . . . . . . . . . .  
 
 
36 
   
Table 3.  Percentage of formation rates for 7β-OOH, 7-keto, 5,6α-EP, and 5,6β-
EP decreased by either genistein or daidzein treatment compared to 
control . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
 
38 
   
Table 4. 
 
Percentage of formation rates for 7β-OOH, 7-keto, 5,6α-EP, and 5,6β-
EP as affected by glycosides mixture compared to control  . . . . . . . . . . .  
 
40 
   
Table 5. Comparison of percentages of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 
7-keto and 7β-OOH accelerated by AAPH with 1 mM different soybean 
isoflavone treatment after 24 hr or 48 hr of reaction  . . . . . . . . . . . . . . . .  
 
 
41 
   
Table 6. Comparison of cell viabilities after different concentrations of genistein 
or daidzein treatment   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
44 
   
Table 7. Comparison of cell viabilities of the 500 µM group (C group) in 
cytotoxicity study of tBOOH and the control groups in method A (A 
group) and method B (B group)  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
 
49 
 
 
  vi    
 List of Figures 
 
 
Figure 1.  Structures of daidzein, genistein, and glycitein  . . . . . . .  . . . . . . . . . . .  6 
   
Figure 2. Chromatogram of crude soybean isoflavone extract in the reversed-
phase preparative HPLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
31 
   
Figure 3. Chromatogram of high-purity soybean isoflavones in the analytical 
reversed-phase HPLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
31 
   
Figure 4. Major pathways of cholesterol oxidation . . . . . . . . . . . . . . . . . . . . . . . .  32 
   
Figure 5. Chromatogram of cholesterol oxidation products after 24 hr of 
oxidation with 5 mM AAPH and 10 mM cholesterol  . . . . . . . . . . . . . .  
 
33 
   
Figure 6. Percentage of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 7-keto, and 
7β-OOH accelerated by AAPH at different oxidation times . . . . . . . . .  
 
33 
   
Figure 7. Percentage of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 7-keto and 
7β-OOH accelerated by AAPH with or without soybean isoflavone 
treatment after 24 hr or 48 hr of reaction . . . . . . . . . . . . . . . . . . . . . . . .  
 
 
36 
   
Figure 8.  Percentage of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 7-keto, and 
7β-OOH accelerated by AAPH with or without soybean isoflavone 
treatment at different oxidation times . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
 
38 
   
Figure 9. Percentage of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 7-keto, and 
7β-OOH accelerated by AAPH with or without glycosides mixture 
treatment at different reaction times  . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
 
40 
   
Figure 10. The growth curve of SVEC-4-10 cells with the plated cell density of 
8.7×104 cell/cm2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
42 
   
Figure 11. Effect of soybean isoflavones on the viability of SVEC4-10 cells over 
a concentration ranging from 0 µM to 50 µM for 24 hrs . . . . . . . . . . . .  
 
43 
   
Figure 12. Decreased viability of SVEC4-10 cells in response to increasing 
concentration of tBOOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
45 
   
Figure 13. Cellular viability after soybean isoflavone treatment against oxidative 
stress caused by tBOOH on SVEC4-10 cells (method A) . . . . . . . . . . .  
 
47 
   
Figure 14. Cellular viability after soybean isoflavone treatment against oxidative 
stress caused by tBOOH on SVEC4-10 cells (method B) . . . . . . . . . . .  
 
47 
  vii    
Abstract 
 
            An efficient procedure was developed and used to extract and purify isoflavones 
from defatted soy flour. The purity of the final product reached 94%. The antioxidant 
activities of soybean isoflavones (genistein and daidzein purchased from Sigma Chemical 
Co, and a mixture of isoflavone glycosides extracted from defatted soy flour) were 
investigated by a cholesterol oxidation model accelerated by 2,2-azobis(2-
methylpropionamidine) dihydrochloride (AAPH). All components exhibited very high 
antioxidant activities in the inhibition of cholesterol oxidation. Genistein had higher 
inhibition to the formation of 5,6beta-epoxycholesterol (5,6β-EP) and 7-ketocholesterol 
(7-keto), while no significant difference was found between the antioxidant activities of 
daidzein and genistein against cholesterol oxidation to 7beta-hydroperoxycholesterol (7β-
OOH) and 5,6alpha-epoxycholesterol (5,6α-EP). The glycosides mixture had 
characteristics similar to genistein and daidzein in preventing cholesterol oxidation, but 
the glycosides mixture was found to have lower antioxidant activities compared to 
aglycones. The biological activities of genistein and daidzein to affect cellular response 
in SVEC4-10 mouse endothelial cells to t-butyl hydroperoxide-induced oxidative stress 
were also evaluated. Genistein had higher cytotoxicity than daidzein to SVEC4-10 cells 
and none exerted discernable antioxidant activities in this cell culture model. The 
antioxidant activities of soybean isoflavones may contribute to their potential role in 
reducing the formation of certain types of cancers, so daidzein might be a more 
appropriate cancer preventive neutraceutical because of its lower cytotoxicity. In view of 
the high cytotoxicity, this cell culture model might not be suitable for the study of 
  viii    
antioxidant activity of soybean isoflavones. Some modifications or another cell culture 
model is needed in order to further this study of antioxidant activity. Defatted soy flour is 
a by-product of oil extraction, so the antioxidant activities of soybean isoflavones could 
improve the utilization of the by-product and benefit the soy industry. 
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Chapter 1 
Introduction 
 
            Soy foods have received considerable attention of late for their potential role in 
reducing the formation and progression of certain types of cancers and some chronic 
diseases such as cardiovascular disease, Alzheimers disease, and osteoporosis (Messina, 
1999; Messina and Bennink, 1998; Clarkson and Anthony, 1998; Zhao et al., 2002; 
Anderson and Garner, 1998). Several mechanisms have been proposed, such as lowering 
oxidative stress, stimulating or inhibiting estrogen receptor, and preventing the 
proliferation of cells, but the specific mechanism is still under study (Tikkanen et al., 
1998; Mitchell et al., 1998; Maggiolini et al., 2001; Hempstock et al., 1999). Oxidative 
stress has been associated with several cell toxic processes including oxidative damage to 
protein and DNA, membrane lipid oxidation, enzyme inactivation, and gene mutation that 
may lead to carcinogenesis, so lowering oxidative stress might be an effective way to 
prevent the formation of cancers and other chronic diseases (Paulsen et al., 1998). Several 
anti-carcinogens, including isoflavones, have been identified in soybeans, but soybean 
isoflavones might be the most likely one because of its antioxidant activity through its 
phenol structure, which maintains the redox balance of normal cells.  
            Because more than 70% of isoflavones are left in defatted soy flour, a by-product 
of oil extraction, defatted soy flour would be an economical resource for isoflavone 
extraction. Although considerable research has been carried out to investigate soybean 
isoflavones antioxidant activities, the underlying mechanisms need to be elucidated. 
More over, most of the antioxidant activity studies were done with genistein, the major 
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component of soybean isoflavones. For example, genistein was studied in an oxidation 
model elicited by UVB irradiation and was found to substantially inhibit a series of 
oxidative events, including hydrogen peroxide (H2O2) production, lipid peroxidation, and 
8-hydroxy-2-deoxyguanosine (8-OHdG) formation (Wei et al., 2002). Genistein was also 
studied in a low-density lipoprotein (LDL) oxidation model initiated by copper and 
peroxy radicals and was found to inhibit LDL oxidation (Uesugi et al., 2002). Daidzein is 
another major component of soybean isoflavones but much less research has been done 
with it. So the objectives of this research were to explore a procedure to efficiently 
extract and purify isoflavones from defatted soy flour, to investigate the mechanisms 
underlying soybean isoflavones antioxidant activities, and to evaluate and compare the 
antioxidant activity of daidzein and genistein. 
            The antioxidant activities of soybean isoflavones have been studied with different 
models with the LDL oxidation model being the most popular. Cholesterol is an essential 
molecule for humans as a component of cell membrane and as the precursor of steroid 
hormones and bile acids, but cholesterol oxidation products (COPs) are considered to be 
mutagenic and carcinogenic compounds and may cause cardiovascular disease 
(Panniangvait et al., 1995; Carpenter 2002; Woods and OBrien, 1998; Wilson et al., 
1997; Kumar, 1991). So, an antioxidant activity study using a cholesterol oxidation 
model would be practical and of great importance as well.  
            Initiated by free radicals, cholesterol is oxidized to hydroperoxides, peroxides, 
epoxides, and other degradation products (Smith 1987; Yan and White, 1990; Nam et al., 
2001). 7-Hydroperoxycholesterol (7-OOH) is the primary cholesterol oxidation product 
with 5,6-epoxycholesterol (5,6-EP), 7-ketocholesterol (7-keto), and 7-hydroxycholesterol 
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(7-OH) as the secondary oxidation products produced after 7-OOH is epoxidized, 
dehydrated, and reduced. Seven cholesterol oxidation products, 5,6alpha-
epoxycholesterol (5,6α-EP), 5,6beta-epoxycholesterol (5,6β-EP), 7-ketocholesterol (7-
keto), 7alpha-hydroperoxycholesterol (7α-OOH), 7beta-hydroperoxycholesterol (7β-
OOH), 7alpha-hydroxycholesterol (7α-OH), 7beta-hydroxycholesterol (7β-OH), were 
found during heating of cholesterol (Chien et al., 1998). Similar to lipid oxidation, 
cholesterol oxidation in the human body is dominated by free radical chain reactions, so 
the oxidation model with heating may not be appropriate to predict cholesterol oxidation 
status in the human body. An aqueous free radical reaction initiator, 2,2-azobis(2-
methylpropionamidine) dihydrochloride (AAPH), has been used to accelerate cholesterol 
oxidation with a reaction temperature of 37oC, which is at relatively similar conditions to 
the human body (Xu et al., 2001). It is more appropriate to use this model to evaluate the 
antioxidant activity for compounds of interest against cholesterol oxidation.  
            Vascular cells, especially endothelial cells are easily attacked by free radicals and 
the dysfunction of endothelial cells is involved in the progression of athrogenesis. In this 
research, the effect of soybean isoflavones, genistein or daidzein, on oxidative injury to 
cultured mouse endothelial cells (SVEC4-10) was examined.  Oxidative injury was 
induced by tert-butyl hydroperoxide (tBOOH), which is an organic hydroperoxide widely 
used as a model compound to induce oxidative stress (Buc-Calderson et al., 1991; Mirella 
et al., 1998). SVEC4-10 is an endothelial cell line derived by SV40 transformation of 
endothelial cells from mouse auxillary lymph node vessels. They could grow infinitely 
without special addictives and are well differentiated, responding like normal endothelial 
cells to some interleukins and to extra-cellular matrix signals for tube-like differentiation. 
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After a latency period of 14 weeks, they would induce spindle tumors with some of the 
histo-pathologic characteristics of human Kaposi Sarcoma. An understanding of how 
soybean isoflavones protect SVEC4-10 from oxidative injury in vitro would help to 
clarify how they exert biological activity in vivo.  
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Chapter 2 
Overview of the Mechanisms for Soybean Isoflavones Health Improvement 
Actions 
 
 
2.1 Introduction 
            More and more evidence indicates that soybean isoflavones may offer protection 
against a wide range of human conditions, including breast, bowel, prostate and other 
cancers, cardiovascular disease, brain dysfunction, alcohol abuse, osteoporosis and 
menopausal symptoms. Several mechanisms for their protective function have been 
proposed, although the exact mechanisms have not been identified. Soybean isoflavones 
have antioxidant activity, may influence the production, metabolism and biological 
function of sex-hormones, may affect the synthesis and activity of intracellular enzymes, 
may change growth factor action, malignant cell adhesion, proliferation, and 
differentiation. These factors alone or in some combination contribute protective 
functionality to human health. The mechanisms will be reviewed here according to their 
specific actions, such as anti-cancer action, cardiovascular system protective action and 
anti-osteoporosis action. 
2.2       Anticancer Actions 
2.2.1    Cancer Preventive Function 
            The anticancer action of soybean isoflavones is focused mainly on their cancer 
preventive function. Epidemiological evidence and studies in cancer models suggest that 
isoflavones play an important role in cancer prevention. For example, the consumption of 
soy products, which contain a mixture of soybean isoflavones, may contribute to the 
relatively lower rates of breast, colon, and prostate cancer in countries such as Japan and 
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China (Messina et al., 1994). However, the exact biological mechanisms underlying this 
effect remain to be fully elucidated.  
            The most tenable mechanism being postulated for soybean isoflavones cancer 
preventive function is that soybean isoflavones have strong antioxidant capacity. The 
structures of three main soybean isoflaovones, genistein, daidzein, and glycitein are 
shown in Figure 1. The two pharmacophores that account for soybean isoflavones 
antioxidant activity are the 4 hydroxyl group on the B-ring and the hydroxyl groups on 
the AC-ring. All of them could be hydrogen/electron donators (Heijnen et al., 2002). 
 
 
 
R1             R2 
H               H            Daidzein 
OH            H            Genistein 
H              OCH3         Glycitein 
 
Figure 1.  Structures of daidzein, genistein, and glycitein. 
 
            Free radicals, such as reactive oxygen species (ROS) and reactive nitrogen species 
(RNS), could be formed endogenously as the result of normal oxidative metabolic 
reactions; exogenously as the components of tobacco smoke, diet, drugs, and other 
environmental pollutants; and indirectly through radiation and metabolism of certain 
solvents. These reactive compounds will react with and potentially alter the structure and 
function of several cellular components, such as lipid-contain cell membranes, 
lipoproteins, RNA and DNA, and cause the formation of a variety of chronic diseases 
O
O OH
OH
R1
R2
     AC-ring             B-ring 
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such as cancer, cardiovascular disease, cataract formation, aging process and some 
neurological disorders (Rock et al., 1996). As a complicated entity, the human body itself 
has an antioxidant defense system that prevents free radical formation and removes 
radicals before oxidative damage can occur, but oxidative damage can still result when 
the critical balance between free radical generation and antioxidant defenses is 
unfavorable. Interaction of free radicals with DNA bases can result in the formation of 
DNA adducts which, during the course of attempted replication, can lead to DNA 
mutation. Accumulation of DNA mutations (specifically in crucial genes) contributes to 
the development of neoplastic cells. Indeed, free radicals have been shown to possess 
many characteristics of a carcinogen (Wiseman and Halliwell, 1996). Antioxidants are 
thought to decrease the incidence of cancer formation because antioxidants could fight 
against free radicals directly as free radical scavenger and maintain the normal 
antioxidant defense system through protecting or reducing endogenous antioxidant 
enzymes. 
            As with other antioxidants, soybean isoflavones may exhibit their cancer 
preventive function through their antioxidant properties. Genistein, the major component 
of soybean isoflavones, has been demonstrated to inhibit ultraviolet-B (UVB)-induced 
skin tumorigenesis in hairless mice. The antioxidant properties of genistein may explain 
the mechanisms of its anti-photocarcinogenic action because through either direct 
quenching of reactive oxygen species or indirect anti-inflammatory effects, genistein was 
found to substantially inhibit a series of oxidative events elicited by UVB irradiation, 
including hydrogen peroxide (H2O2) production, lipid peroxidation, and 8-hydroxy-2-
deoxyguanosine (8-OHdG) formation (Wei et al. 2002). In an in vitro model, calf thymus 
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DNA was used to investigate the inhibition of genistein on UV light and Feton reaction-
induced oxidative DNA damage. Genistein potently scavenges both hydrogen peroxide 
and superoxide anions, which suggests genistein has potential anti-carcinogenic function 
in photocarcinogenesis through its antioxidant property (Wei et al., 1996).   
            Soybean isoflavones are also effective in decreasing the oxidative stress caused 
by other tumor promoters, such as 12-O-tetradecanoyphorbol-13-acetate (TPA) and 
xanthine/xanthine oxidase. Genistein strongly inhibits the H2O2 formation induced by 
TPA both in vivo and in vitro (Wei et al., 1993). In the model of HL-60 cells, both 
genistein and daidzein have strong inhibition to TPA induced H2O2 formation, while 
daidzein only shows a moderate inhibitory effect to O2- generation caused by 
xanthine/xanthine oxidase. This shows that the antioxidant properties of soybean 
isoflavones are structurally related and the authors found that the hydroxyl group at 
position 4 is crucial for their antioxidant property (Wei et al., 1995). 
            Directly preventing oxidative stress is just one of the mechanisms through that 
soybean isoflavones exhibit their cancer preventive function. Soybean isoflavones 
chemopreventive action could also arise from their promotion of endogenous antioxidant 
enzymes, such as catalase, superoxide dismutase, glutathione peroxidase and glutathione 
reductase. Dietary administration of genistein (50 and 250 ppm) for 30 days significantly 
increases the activities of antioxidant enzymes in various organs of SENCAR mice 
(Mahwah, 1996). Soybean isoflavones extract normalized total hepatic glutathione 
peroxidase activity, which was suppressed about 17% by phenobartital (PB) (Lee et al., 
1995). Soybean isoflavones could act at either the transcription level or the protein level 
to influence the activities of endogenous antioxidant enzymes, but the specific 
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mechanism has not been identified. In a model of hepatoma H4IIE cells, daidzein 
treatment increased catalase mRNA expression. Transfection experiments were 
performed in order to elucidate the underlying mechanism and the results showed that 
daidzein could directly activate the rat catalase promoter region (Rohrdanz et al., 2002). 
Genistein was also found to increase the expression of glutathione peroxidase (GPx)-1 in 
two prostate-cancer cell lines (Suzuki et al., 2002). On the other hand, Wiseman 
hypothesized that soybean isoflavones may influence the activity of membrane enzymes 
by stabilizing the membrane against lipid peroxidation and decreasing the membrane 
fluidity (Wiseman et al., 1993). 
            Other mechanisms have been explored to explain soybean isoflavones cancer 
preventive function besides their antioxidant activity. For example, it was suggested that 
isoflavones cancer preventive function involves the modulation of estrogen synthesis 
and metabolism because pre-menopausal women with regular soy diets had decreased 
estrogen synthesis and different metabolism pathways compared to a control group (Xu et 
al., 1994). Genistein and daidzein may interfere with the expression of SOS response, 
that is part of cellular stress response and will cause error-prone repair. Genistein 
decreased both transition and transversion mutation induced by the carcinogen N-ethyl-
N-nitrosourea (ENU) via suppressing the SOS response, and both genistein and daidzein 
suppressed the SOS response in Salmonella typhimurium TA1535/pSK1002 against the 
effect of mutagens, such as of 3-amino-1,4-dimethyl-5H-pyrido[4,3b]indole (Trp-P-1), 
furylfuramide, and activated Trp-P-1 (Yang and Fix, 2001; Miyazawa et al., 1999). 
Genistein and daidzein could inhibit the CYP1A1 enzyme activity induced by 2,3,7,8-
tetracholorodibenzo-p-dioxin (TCDD; dioxin) (Shertzer et al., 1999). CYP1A1 enzyme 
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catalyzes the formation of benzo[a]pyrene (BaP) metabolites that will ultimately cause 
DNA mutation. Soybean isoflavones do not work at the transcription level against the 
activity of CYP1A1, as daidzein does against catalase. Instead, soybean isoflavones 
compete non-competitively with the CYP1A1 substrate BaP for microsomal 
hydroxylation to protect against carcinogenesis caused by BaP. Genistein was also found 
to significantly inhibit the expression of TPA-induced proto-oncogen (c-fos), which may 
help prolong tumor latency and decrease tumor multiplicity (Wei et al., 1995). In an 
animal model of F344 rats, the diet containing genistein and daidzein mixture decreased 
the development of adenocarcinomas induced by 3, 2-dimethy-4-aminobiphenyl 
(DMAB) and testosterone propionate (TP). It was found that the argyrophilic nuclear 
organizer regions (AgNORs) in adenocarcinomas were significantly inhibited by the 
soybean isoflavone mixture (Onozawa et al., 1999).  
            The effective scavenging of reactive radicals and low reactivity of generated 
secondary antioxidant radicals towards vital intracellular components are two critical 
requirements for a chain-breaking antioxidant. However, an antioxidant may act as a 
prooxidant according to the oxidative tension and antioxidant concentration. For 
example, beta-carotene may help to increase protein oxidation and DNA damage with 
low oxygen (O2) tension and high concentration (Zhang and Omaye, 2001). Alpha-lipoic 
acid and didydrolipoic acid, known as antioxidants, may also exert prooxidant properties 
in vivo (Moini et al., 2002). This characteristic may also apply to soybean isoflavones. 
Daidzein exerted a mild oxidative stress in H4IIE cells, which was recovered by 
daidzeins promotion to an antioxidant enzyme system (Rohrdanz et al., 2002). 
Moreover, the antioxidant action may be a shift from one oxidation to another oxidation. 
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For instance, catechol-containing antioxidant exerted antioxidant activity through shifting 
lipid oxidation to sulfhydryl arylation (Boots et al., 2002). So there could also be a 
concern that the antioxidant activity of soybean isoflavones does not necessarily help 
decrease the incidence of cancer formation.  
            At present, as a cancer preventive substance, soybean isoflavones are being 
incorporated into new foods in excess of naturally occurring concentrations, but it should 
be pointed out that the safety margin of soybean isoflaovens is relatively narrow and 
toxicity assessment should be carried out. Meanwhile, the cancer preventive effects could 
be the result of associated dietary or lifestyle factors. The results of Lee et al., 1995, 
showed that, with a dose of 1,840 µM/kg, soybean isoflavones might have cancer-
promoting function in female F344/N rats initiated with diethylnitrosamine (DEN). In 
Japan, the serum level of daidzein non-metabolizer was examined both in prostate 
patients and in healthy persons. It was found that the prostate cancer patients had a 
significantly higher serum level of daidzein non-metabolizer compared to control group, 
so the authors postulated that daidzein non-metabolizer might be a risk factor for prostate 
cancer (Akaza et al. 2002).  
2.2.2 Cancer Inhibitory Function 
            Cancer inhibitory function of soybean isoflavones comprises the second aspect of 
their anti-cancer action. Soybean isoflavones could inhibit the growth of most types of 
hormone-dependent and hormone-independent cancer cells in vitro, including breast, 
prostate, colorectal and colon cancer cells. The reported mechanisms for their cancer 
inhibitory function are regulation of estrogen-mediated events, inhibition of tyrosine 
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kinase and DNA topoisomerase activities, synthesis and release of TGF beta and 
modulation of the differentiation and cell cycle through changing gene expression. 
            Estrogen plays multiple hormonal roles in human health, among which, mitogenic 
action of estrogen is the most important to the reproductive system, bones, heart and 
possibly the brain. There is a common structural characteristic between estrogen and 
soybean isoflavones, the presence of a phenolic ring, which is the prerequisite for binding 
to the estrogen receptor. However, soybean isoflavones only have weak estrogenic 
properties, which enable them to act as anti-estrogens by competing with estrogen for 
binding to the estrogen receptor and inhibit the mitogenic actions of estrogen, thus 
exerting the cancer inhibitory function. The binding and activation of estrogen receptor 
by genistein, daidzein, and glycitein have been studied. The results established that all of 
them could bind to and activate estrogen receptor, although the binding affinity and 
activation potency was much lower than that of estradiol (Song et al., 1999). On the other 
hand, in the test with yeast estrogen screen, only genistein was found to induce an 
estrogen signal, while no signal was detected for either daidzein or glycitein (De-Boever 
and Verstraete, 2000). The estrogenic activity of genistein has also been studied in a 
MCF-7 cell line. The genistein-bound estrogen receptor was processed in the nucleus at 
about the same rate as the estradiol-bound receptor, but was less effective than estradiol 
in translocating the cytoplasm estradiol receptor to the nucleus (Wei et al., 2002). 
            An alternative theory postulated by some scientists indicates that, instead of 
inhibiting the growth of cancer cells, soybean isoflavones might exert proliferative action 
to cancer cells through estrogen receptors. The research of Maggiolini et al., 2001, 
demonstrated that estrogen receptor mediates the proliferative but not the cytotoxic dose-
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dependent effects of soybean isoflavones on two breast cancer cells. Still others insist that 
the inhibitory effect of soybean isoflavones to cancer cells is unrelated to estrogen 
receptor because soybean isoflavones are equally effective against either estrogen 
receptor dependent or estrogen receptor independent cancer cells. For example, Genistein 
was found to induce the differentiation of both MCF-7 and MDA-468 cells, but daidzein 
did not induce differentiation to either MCF-7 or MDA-46 (Constantinou et al., 1998). 
            The cancer inhibitory effect of soybean isoflavones might also arise from their 
influence on the biosynthesis and metabolism of estrogen and the expression of estrogen 
receptor. Estradiol level of genistein-treated monkeys was higher than that of control 
group. The reasonable explanation might be that genistein may stimulate the de-
conjugation of estrone in the gut, thus allowing its re-absorption into the peripheral 
circulation and conversion to estradiol (Harrison et al., 1999). In the model of prepubertal 
rat, pharmacological, but not physiological concentrations of genistein were found to 
modulate the expression of sex steroid receptors in the uterus, including estrogen 
receptors (Cotroneo et al., 2001). 
            There are several other mechanisms through which soybean isoflavones exert 
their cancer inhibitory effect and inhibiting the activity of protein tyrosine kinase is one 
of them. Tyrosine kinase is involved in the signal cascade that ultimately leads to cell 
survival and cell division, so decreased tyrosine kinase activity helps to inhibit the 
proliferation of cancer cells. In addition, the phosphorylated state of estrogen receptor 
may also influence the receptor activity, thus decreased tyrosine kinase activity might be 
associated with soybean isoflavones hormonal influence on cancer cells (Dayani et al., 
1990). However, genistein has been found to inhibit both the serum-stimulated and 
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epidermal growth factor (EGF)-stimulated growth of human prostate cells and had no 
significant effect on the EGF receptor tyrosine autophosphorylation. It was suggested that 
the cancer inhibitory action of genistein was dependent not on the inhibition of EGF 
receptor autophosphorylation but on a more distal event in the EGF-receptor mediated 
signal transduction cascade (Peterson and Barns, 1993). In a model of human prostate 
cancer cells, genistein treatment decreased the expression of mitogen-activated protein 
kinase 6 (MAPK 6), which is in accordance with the former hypothesis because MAPK is 
one of the distal events of receptor tyrosine kinase (Suzuki et al., 2002).  
            Mechanisms other than PTK inhibition have also been postulated to be involved 
in soybean isoflavones cancer inhibitory action. In a cell model study, both genistein and 
TGF beta were found to suppress the epidermal growth factor (EGF) stimulated 
proliferation of human mammary epithelial (HME) cells and genistein treatment 
increased the level of TGF beta in a medium of cells through either increased synthesis or 
decreased degradation. It was suggested that the cancer inhibitory action of soybean 
isoflavones might involve modulating TGF beta activity (Kim et al. 2001). 
            The last major mechanism by which soybean isoflavones exert their cancer 
inhibitory action is by changing the cells gene expression thus inducing cell 
differentiation or cell cycle arrest. Four human melanoma cell lines and one B16-B16 
mouse melanoma cell line have been used to investigate the growth inhibitory and 
differentiation inducing action of genistein (Rauth et al., 1997; Yan et al., 1999). 
Genistein significantly inhibited cell growth and the chemosensitivity might have 
depended on the content of p53, the cellular tumor suppressor, because higher levels of 
wild-type p53 expression make cells more resistant to genisteins growth-inhibitory 
  15    
action. Moreover, in the mouse melanoma cells, genistein was found to increase the 
expression of p53 and decrease the expression of c-Myc protein. With respect to cell 
differentiation, genistein induced the cytoskeletal filaments to form a bundle along the 
direction of elongation of the cells and caused the cells to form dendrite-like structure. 
The tyrosine phosphorylation levels of cytoskeleton-associated proteins decreased after 
the genistein treatment. The differentiation inducing effect of genistein is also p53 
dependent because cells lacking p53 responded more than cells with p53 through 
dendrite-like structure formation. The decreased phosphorylation level might arise from 
the increased tyrosinase activity. It was observed that genistein affected tyrosinase 
activity at the transcription level because genistein treatment increased the tyrosinase 
mRNA level. Genistein could cause G2/M arrest in cell cycle progression in various 
cancer-cell lines, but in contrast to the differentiation effect of genistein, the cell cycle 
arrest effect was p53 independent. In human hepatocellular Hep G2 and colorectal 
Colo320 HSR carcinoma cells, genistein strongly increased the expression of p21 protein, 
a cyclin-dependent kinase (Cdk) inhibitor, in experimental conditions through activating 
p21 promoter reporter constructs to cause G2/M arrest (Park et al., 2001). In two 
hormone-sensitive cell lines T47D and ZR75.1 and two hormone-independent cell lines 
MDAMB-231 and BT20, cell cycle arrest at G2/M phase caused by genistein was 
coupled with the cellular level of p34 proteins. With the exception of the T47D cell line, 
expression of protein p34 was not affected, but the inactivated, tyrosine-phosphorylated 
form of p34, increased after genistein treatment. Protein p62, which is rapidly degraded 
in cycling cells, was also found to accumulate in all cell lines except T47D. Therefore, 
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the authors concluded that genisteins cell cycle arrest effect was coupled with more than 
one protein in all of the studied cell lines (Cappelletti et al., 2000). 
            Several other mechanisms have been postulated to elucidate the cancer inhibitory 
function of soybean isoflavones: inducing apoptosis, modulating DNA topoisomerase 
activity, stabilizing protein-linked DNA strand breakage, and inhibiting the signal 
transduction pathway. For example, daidzein could induce apoptosis directly without 
altering cell cycle distribution (Su et al., 2000). However, the concentrations being used 
in cell culture study are far above the circulating levels of un-conjugated soybean 
isoflavones in the human body, which points out the limitations of cell culture for the 
study of the cancer inhibitory action of soybean isoflavones. Also, emerging evidence 
indicates that the biological activities of soybean isoflavones may arise from 
modifications to the parent compounds. The hydroxylated and methylated metabolites 
may be the active forms of genistein in human breast-cancer cells (Peterson et al., 1998). 
Apple extracts also have tumor proliferation inhibitory activity, while the inhibitory 
activity might come from the generation of H2O2 during the interaction of phenolic 
compounds with cell culture media (Walker and Kanner, 2002). It is obvious that 
metabolism should be taken into account and the use of reducing agents in cell culture 
media should also be considered in order to exclude the formation of H2O2, or other 
reactive oxygen species when studying the anti-cancer function of soybean isoflavones. 
2.3     Cardiovascular System Protective Actions 
            As with the lower incidence of breast and prostate cancers, a lower incidence of 
heart disease has also been reported in populations consuming large amounts of soy 
products. Great strides have been taken in the approach to mechanisms for the protective 
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action of soybean isoflavones in the cardiovascular system. Soybean isoflavones appear 
to lower serum cholesterol and low-density lipoprotein (LDL) concentrations while 
increasing the plasma concentration of high-density lipoprotein (HDL). Soybean 
isoflavones may increase lipoprotein oxidation resistance and decrease plasma F(2)-
isoprostane concentrations (a bio-marker for in vivo lipid oxidation). They may also 
inhibit the progression of atherosclerosis in the coronary, iliac and common and internal 
carotid arteries. Moreover, the cardiovascular benefits of soybean isoflavones appear to 
be equal for both males and females. 
            High levels of cholesterol and LDL cholesterol are correlated with cardiovascular 
diseases, so any substance that decreases the serum concentration of cholesterol would 
exert cardio-protective action. In a study with 23 healthy postmenopausal women in 
Japan, a soybean isoflavones mixture was found to dramatically decrease total serum 
cholesterol and LDL cholesterol levels (Uesugi et al. 2002). In a cholesterol-fed rabbit 
model, hypo-cholesterol activity of soybean isoflavones was compared to that of estrogen 
replacement therapy (ERT) and 17 beta-estradiol (E2). The results showed that dietary 
phytoestrogens significantly reduced aortic cholesterol content with potency comparable 
to that of ERT and seemed to enhance the anti-atherogenic effect of E2 in this model 
(Alex Andersen et al., 2001). Potential mechanisms by which soybean isoflaovnes induce 
lower blood cholesterol concentration include changing thyroid status, bile acid balance 
and the estrogenic effect (Liechtenstein, 1998). In addition, soybean isoflavones were 
found to decrease lipogenesis and increase lipolysis in isolated rat adipocytes 
(Szkudelska et al., 2000). 
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            Increasing evidence indicates that the antioxidant properties of soybean 
isoflavones may protect human LDL against oxidative modification. For example, 
genistein could inhibit both copper and peroxy radical mediated LDL oxidation (Kerry 
and Abbey, 1998; Hwang et al., 2000). This may be of importance because oxidative 
damage to LDL is considered to be an important stage in the development of 
atherosclerosis. However, soybean isoflavones have different reactivity to the oxidative 
stress caused by copper or peroxy radicals, which suggests an antioxidant mechanism 
other than free radical scavenging.  
            With glucose-derived oxidants, genistein effectively prevented LDL oxidation, so 
it may help to prevent the propagation of diabetic complications such as atherosclerosis 
(Exner et al., 2001). Although only minute amounts of isoflavones could be associated 
with lipoproteins in vivo, LDL isolated from serum still had reduced susceptibility to 
oxidation compared to the control LDL. It was suggested that modified LDL particles had 
been produced in vivo by circulating isoflavones promoting resistance to oxidation ex 
vivo (Tikkanen et al. 1998). Also, it has also been reported that there is no significant 
difference between the oxidation resistances of isolated LDL compared with control LDL 
(Kerry and Abbey, 1998). Different esterified soybean isoflavones have been made in 
order to increase their lipophilicity for incorporation into LDL and oleic acid esters were 
incorporated more effectively than unesterified isoflavones and stearic acid esters (Meng 
et al., 1999). 
            As an anti-atherogenic agent, soybean isoflavones have a number of properties 
besides their inhibitory activity to LDL oxidation. Genistein is a potent inhibitor of 
tyrosine kinase activity and thus it is able to block the activation of growth factors, such 
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as platelet-derived growth factor (PDGF) and basic fibroblast growth factor.  PDGF plays 
an important role in the intimal smooth-muscle cell proliferation that forms part of the 
atherosclerotic process (Wilcox and Blumenthal, 1995). In addition, genistein may reduce 
overall thrombosis associated with atherosclerosis by interfering with platelets and 
thrombin action because genistein could prevent thrombin-induced platelet activation and 
aggregation by inhibiting tyrosine kinase activity (Asahi et al. 1992). Genistein could 
inhibit the cell proliferation involved in lesion formation. For example, genistein inhibits 
the proliferation of many vascular cells, including vascular endothelial cells and also 
inhibits the atherosclerotically important process of angiogenesis (Raines and Ross, 
1995). Furthermore, genistein supplementation was also found to improve endothelial 
dysfunction induced by ovariectomy in rats as well as estrogen replacement therapy does 
(Squadrito et al., 2000). 
2.4     Anti-osteoporosis Actions 
            Osteoporosis is an increasing problem all over the world, but the use of soy-
products has been associated with lower risk of bone fracture in Asian countries. Bone 
loss is the result of unbalanced bone metabolism: decreased bone formation and increased 
bone resorption. In order to elucidate the detailed mechanisms, ovariectomized (OVX) 
rats have been used as an animal model to study the anti-osteoporosis action of soybean 
isoflavones. One study indicated that genistein is useful for regulating B-lymphopoiesis 
and restoring bone loss caused by estrogen deficiency, without estrogenic action in the 
uterus (Ishimi et al., 1999). There are two types of estrogen receptors (ER), ER alpha and 
ER beta.  ER beta predominates in certain estrogen responsive tissues, such as bone and 
bladder and soybean isoflavones could bind to ER beta almost as well as estrogen does; 
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although it binds only weakly with ER alpha, which possibly explains genisteins ability 
to restore bone loss in OVX rats.  
            However, other research has shown that soybean isoflavones could only reduce 
bone turnover dose-dependently but does not reverse established osteopenia. The bone 
loss preventive function of genistein is effective in both orchidectomized male rats that 
are deficient of androgen and ovariectomized female rats that are deficient of estrogen 
(Picherit et al., 2001; Ishimi et al., 2002). In the same study with 23 postmenopausal 
women in Japan, the excretion of bone resorption markers, pyridinoline and 
deoxypyridinoline, was much lower in the isoflavone group compared to the control 
group, which suggested that soybean isoflavones could decrease bone resorption to 
prevent bone loss (Uesugi et al., 2002). Rat osteoclasts have been used as a model to 
study how genistein suppresses osteoclastic bone resorption. Genistein could inhibit 
inward rectifier K(+) current (I(Kir)) in rat osteoclasts thus causing membrane 
depolarization and elevation of Ca(2+) concentration, and finally inhibiting  osteoclastic 
bone resorption (Okamoto et al., 2001). It was also found that genistein could affect 
osteoclastic differentiation of stromal cells through inhibition of topoisomerase 2 (Topo 
2) as other Topo 2 inhibitors do (Yamagishi et al., 2001). In addition, genistein 
administration and moderate exercise showed a cooperative effect in preventing bone loss 
in OVX mice (Wu et al., 2001). 
2.5     Other Applications of Soybean Isoflavones 
            Soybean isoflavones have been suggested as an alternative to estrogen 
replacement in postmenopausal women because they could lessen post-menopausal 
symptoms but not increase the risk of endometrial cancer. Soybean isoflavones 
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administration might reduce hot flashes and vaginal dryness although it does not work as 
efficiently as estrogen replacement therapy (Vincent and Fitzpatrick, 2000). In a study 
with 20 post-menopausal women, soybean isoflavones were found to increase sex 
hormone-binding globulin (SHBG) significantly in subjects whose SHBG concentrations 
were in the lower end of the concentration range (Pino-Ana et al., 2000). However, 
soybean isoflavones do not show estrogenic action on uterus of ovariectomized rat 
(Ishimi et al., 1999). Never the less, soybean isoflavones have been found to work in the 
uterus and even support surgically induced endometriosis (Cotroneo and Lamartiniere, 
2001). However, the current data are insufficient and more animal studies and pre-clinical 
experiments are needed regarding isoflavones anti-post-menopausal symptom actions. 
            Soybean isoflavones may also have neuroprotective efficacy due to their 
antioxidant activity because neuronal cell death caused by oxidative stress may contribute 
to the pathogenesis of neurodegenerative diseases, such as Alzheimers disease and 
Parkinsons disease. However, in a study with cultured hippocampal neurons, soybean 
isoflavones were not functional equivalents to endogenously active 17-beta-estradiol or to 
estrogen replacement formulations, although it did exert some neuroprotective effects. 
Therefore, it has been suggested that soybean isoflavones would not reduce the risk of 
Alzheimers disease or sustain memory function in postmenopausal women (Zhao et al., 
2002).  
2.6     Future Implications of Soybean Isoflavones 
            The observed health protective actions of soybean isoflavones appear to be 
mediated by a wide range of mechanisms of which antioxidant activity is probably the 
most important. Thus, novel products through soybean isoflavones modification to 
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produce stronger antioxidant activity could be a way to confer even greater protection 
(Ridgway et al., 1996). Also, as it has been pointed out in this review, the bioavailability 
and metabolism of soybean isoflavones are of great relevance to their health 
improvement action because pharmacological and physiological concentrations may exert 
different functions and the biological activity may arise from their modification. 
Genistein-piperamine complex (GP), has been synthesized in order to improve 
genisteins physicochemical properties and the anti-cancer activity of GP was studied and 
compared to that of genistein with HL-60 cells (Polkowski et al., 2000). Genistein-amine 
complex did not loose the activity of the parent compound because the measured anti-
cancer effects of GP and genistein were qualitatively and quantitatively similar. 
However, there are considerable individual differences in the bioavailability and 
metabolism of soybean isoflavones. For example, the conversion by gut micro-flora of 
daidzein to its isoflavone metabolite equol, which is a more potent estrogen and 
antioxidant, occurs only in some individual (Wiseman, 2000). So it would be much more 
practical if the administration of soybean isoflavones could be individually controlled. 
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Chapter 3 
Materials and Methods 
 
3.1 Extraction and Purification of Soybean Isoflavones 
3.1.1 Chemicals 
            HPLC grade hexane, methanol, and ethanol were purchased from Fisher 
Chemicals (Fair Lawn, NJ). 
3.1.2 Extraction of Soybean Isoflavones 
            Soybeans obtained from Delta Grow Seed Company (England, AR) were ground 
to flour. The flour was defatted using hexane. The mixture of 100 mL of hexane and 50 g 
of soy flour was shaken at room temperature for 1 hr. The supernatant was removed after 
the mixture was centrifuged at 1000g for 20 min. The defatted soy flour was dried under 
a hood overnight. 
            Methanol was used as solvent to extract isoflavones from the defatted soy flour. 
The defatted soy flour was mixed with 80 mL of methanol. The extraction conditions and 
procedure were the same as that in defatting. The supernatant was placed under nitrogen 
flow to evaporate the solvent to a final volume of approximately 10 mL (Xu et al., 2002). 
3.1.3 Purification and Quantification of Daidzin, Glycitin, and Genistin 
            The preparative HPLC system consisted of a Waters (Milford, MA) PrePak RCM 
base packed with two 25 mm×10 cm Prep Nova-Pak HR C18 (particle size 6 µm) 
cartridges and a Guard-Pak insert, a Delta Prep 4000 HPLC system, and a 481 LC 
spectrophotometer detector. Millennium32 Chromatography Manager (Waters) was used 
to record the chromatogram. The composition of water and methanol in mobile phase was 
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99:1 (v/v) for the first 20 min, then 50:50 for 10 min, and 0:100 for the last 15 min. The 
flow rate of mobile phase was 15 mL/min and the wavelength of the detector was set at 
254 nm. One mL of isoflavone extract was loaded in the preparative HPLC system each 
time. The fractions of daidzin, glycitin, and genistin were collected and combined (Xu et 
al., 2002). 
            The fractions obtained in the purification were distributed to test tubes in 1 mL 
aliquots. The test tubes were placed under nitrogen flow to evaporate the mobile phase of 
the fraction. The residue of one test tube obtained after evaporation was dissolved in 1 
mL of methanol and analyzed using an analytical HPLC system. The analytical HPLC 
system consisted of a Supelco (Bellefonte, PA) Discovery C18 column (id 3 mm × 25 
cm), a Waters 2690 separation module, a 996 photodiode array detector, and a 
Millennium chromatography manager. The mobile phase was a mixture of water and 
ethanol. The percentage of water in ethanol was from 90% to 50% in 40 min with a 
constant flow rate of 0.3 mL/min and the detector was set at 254 nm. The residue in the 
remaining test tubes was combined and stored at  20oC before use. 
3.2 Antioxidant Activities of Soybean Isoflavones in Preventing Cholesterol 
Oxidation Accelerated by 2,2-Azobis(2-methylpropionamidine) Dihydrochloride 
 
3.2.1 Chemicals 
            Cholesterol, genistein, daidzein, AAPH and Tween 20 were purchased from 
Sigma Chemical Co. (St. Louis, MO). HPLC grade hexane was purchased from Fisher 
Chemicals (Fair Lawn, NJ), and 2-propanol was from Mallinckrodt Co. (Gibbstown, NJ). 
3.2.2 Cholesterol Oxidation System 
            Cholesterol stock solution (12 mM) was prepared by dissolving 0.464 g 
cholesterol in 60 mL of hexane, 37.2 mL of 0.05 M phosphate buffer (pH 6.9), and 2.8 
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mL Tween 20 (Xu et al., 2001). AAPH solution (30 mM) was freshly prepared with 0.05 
M phosphate buffer. The cholesterol oxidation system was composed of 20 mL 
cholesterol stock solution and 4 mL AAPH solution with the concentration of cholesterol 
as 10 mM and the concentration of AAPH as 5 mM.  
            The reaction solution was added to a 100-mL bottle with a Teflon seal disk cap. 
The bottle was placed in a 37oC water bath and shaken at 200 rotations per minute. A 3 
mL aliquot of the reaction solution was sampled at 2hr, 4hr, 6hr, 8hr, 12hr, 24hr, and 48 
hr, and centrifuged at 4000 g to separate the hexane layer from the emulsion.  
            The cholesterol oxidation products in the hexane layer were analyzed using a 
HPLC method (Xu et al., 2001). The system included an Alltech (Deerfield, IL) CN 
column (id 4.6 mm × 150 mm), a Waters 2690 separation module, a 996photodiode array 
detector, and a Millennium chromatography station (Milford, MA). The mobile phase 
was a mixture of hexane and 2-propanol (99 and 1%) at 1.5 mL/min flow rate. Detection 
was at 234 nm. 
3.2.3 Cholesterol Oxidation System Treatment with Soybean Isoflavones 
            Genistein, daidzein or glycosides mixture was added into the cholesterol 
oxidation system to form the experimental groups and the concentration in both molar 
and mass unit of each testing component is listed in Table 1 (average molecular weight 
was used for glycosides mixture). The control had no test mixture added.  
            The reaction solutions of the experimental groups and control group were 
processed as described previously. A 3 mL aliquot of each reaction solution was sampled 
at 2hr, 4hr, 6hr, 8hr, 12hr, 24hr, and 48hr, and centrifuged at 4000 g to separate the 
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hexane layer from the emulsion. The cholesterol oxidation products in the hexane layer 
were analyzed by the same method as in the cholesterol oxidation system. 
 
Table 1. Concentration of each treatment in the reaction system in molar and mass unit 
 
Treatment                            concentration (mg/mL)                 concentration (mM) 
Genistein                                      0.134                                              0.5 
Daidzein                                       0.128                                              0.5         
Glycosides mixture                      0.128                                               0.3 
 
3.2.4     Statistical Analysis 
             The experiment for each test component was repeated three times. The 
experimental data were analyzed by ANOVA using the General Linear Model procedure 
(SAS system, SAS Institute Inc., Cary, NC) with significant differences between means 
separated using Turkeys test at p<0.05. 
3.3 Antioxidant Activities of Soybean Isoflavones on tert-Butyl Hydroperoxide-
Induced Oxidative Stress in SVEC4-10 Cells 
 
3.3.1 Chemicals 
            Genistein, daidzein, tBOOH, Hanks balanced salts and MTT based in vitro 
toxicology assay kit were purchased from Sigma Chemical Co. (St. Louis, MO). 
Dimethyl sulfoxide (DMSO) was purchased from Mallinckrodt Co. (Paris, KY). Sodium 
bicarbonate was from J. T. Baker Chemical Co. (Phillipsburg, NJ). 
3.3.2 Cell Culture and Cell Growth Curve 
            Mouse endothelial cells (SVEC4-10) were maintained at the surface of Costar cell 
culture flasks at 37oC under 5% CO2 and 95% air in Dulbeccos modified Eagles 
medium (DMEM) supplemented with 10% fetal bovine serum, 4.5 g/L glucose and 4 mM 
L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate. The ratio of medium volume 
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to growth area was 3 and this was applied to both cell culture flasks and plates. Cells 
were plated out in individual wells of 24-well Costar plates at a density of 8.7×104 cells 
per cm2 (666 uL per well) and then the growth of cells was investigated in a series of 6 
days by cell counting with Trypan blue exclusion. 
3.3.3 Cytotoxicity Study of Genistein and Daidzein 
            Cells were plated out in individual wells of 96-well Costar plates at a density of 
2×105 cells per cm2 (100 uL per well). On the second day, the culture medium was 
removed and the cells were re-incubated in Hanks balanced salts solution with or without 
either genistein or daidzein (dissolved in DMSO with the final concentration of DMSO in 
Hanks balanced salts solution as 0.7%) at concentrations of 100, 50, 25, 10, 5, 2.5, 1, 0.5, 
and 0.25 µM for 24 hrs (100 µM solution with 0.7% DMSO was used as stock solution to 
be diluted by Hanks solution with 0.7% DMSO to obtain different concentrations). Then 
the soybean isoflavone solution was removed at day three and cell viability was measured 
using the MTT method and expressed as a percentage of total cellular activity. The MTT 
method is a means of measuring the activity of living cells via mitochondrial 
dehydrogenases and it is simple, accurate and yields reproducible results. The key 
component is (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenol tetrazolium bromide) or MTT. 
Solutions of MTT, dissolved in balanced salts solution without phenol red, are yellowish 
in color. Mitochondrial dehydrogenases of viable cells cleave the tetrazolium ring, 
yielding purple formazan crystals that are insoluble in aqueous solutions. The crystals are 
dissolved in acidified isopropanol and the resulting purple solution is 
spectrophotometrically measured at 570 nm. An increase or decrease in cell number 
  28    
results in a concomitant change in the amount of formazan formed, indicating the degree 
of cytotoxicity caused by the test material (Mossman, 1983).  
3.3.4 Cytotoxicity Study of tBOOH 
            Cells were plated out at the same density and same volume in individual wells of 
96-well Costar plates. At day three, the culture medium was substituted with Hanks 
balanced salts solution with or without different concentration of tBOOH (500, 250, and 
100 µM) for 0, 1, 2, 3, 4, and 5 hrs and then cell viability was measured using the MTT 
method and expressed as a percentage of total cellular activity. 
3.3.5 Cell Treatment with Soybean Isoflavones 
            Two approaches were used in this experiment to investigate the antioxidant 
activity and mechanism of genistein and daidzein. In the first approach  (method A), on 
the third day after cells were plated out in a 96-well plate, cells were re-incubated in 
Hanks balanced salts solution with the concentration of tBOOH at 500 µM with or 
without either 1 µM genistein or 1 µM daidzein for 0, 1, 2, 3, 4, and 5 hrs. Then the cell 
viability was measured using the MTT method and expressed as a percentage of total 
cellular activity. In the second approach (method B), cell culture media was substituted 
with Hanks balanced salts solution with or without either 1 µM genistein or 1 µM 
daidzein for 24 hrs on the second day after the cells were plated out in a 96-well plate. 
Then the soybean isoflavone solution was discarded on the third day and the cells were 
washed with Hanks solution three times in order to remove the un-attached soybean 
isoflavones before the cells were re-incubated in tBOOH solution with a concentration of 
500 µM for 0, 1, 2, 3, 4, and 5 hrs. After that the cell viability was measured using the 
MTT method and expressed as a percentage of total cellular activity. 
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3.3.6 Statistical Analysis 
            Each experiment was replicated three times and each replication had four 
repetitions. The mean of the four repetitions was used and the results are presented as 
mean ± SE (standard error). Statistical analysis was performed using a one-factor analysis 
of variance (ANOVA). Probability of p < 0.05 was considered statistically significant. 
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Chapter 4 
Results and Discussion  
 
4.1 Extraction and Purification of Soybean Isoflavones 
4.1.1 Purification and Quantification of Daidzin, Glycitin, and Genistin 
            Although approximately 25% of soybean isoflavones were lost in the hexane 
defatting procedure, the lipids of soy flour that could reduce the separation efficiency of 
preparative scale HPLC were largely removed at the same time. In order to prevent any 
possibility of enzymatic hydrolysis that could break down the glycoside group of daidzin, 
glycitin, and genistin and lower their extraction yield, only methanol was used in the 
soybean isoflavones extraction. Figure 2 is the chromatogram of soybean isoflavones 
extract in the preparative scale HPLC. The three isoflavone fractions inside the dotted 
line frame were collected. The chromatogram of the collected fractions in the analytical 
HPLC system is shown in Figure 3 with the three peaks representing daidzin (peak 1), 
glycitin (peak 2), and genistin (peak 3), respectively, identified according to standard 
retention times (Xu et al., 2002). As most impurity compounds were eliminated after the 
purification in the preparative scale HPLC, the three isoflavones peaks were the major 
peaks and occupied about 94% of the total peak area in the chromatogram. 
4.2 Antioxidant Activities of Soybean Isoflavones in Preventing Cholesterol 
Oxidation Accelerated by 2,2-Azobis(2-methylpropionamidine) Dihydrochloride 
 
4.2.1 Cholesterol Oxidation Products with AAPH Acceleration 
            To date, more than 80 cholesterol oxidation products (COPs) have been described 
and different COPs will be generated under different conditions. 7α-OH, 7β-OH and 7-
keto were found to be the major COPs in cooked meat (Du et al., 2001), while the most  
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Figure 2. Chromatogram of crude soybean isoflavone extract in the reversed-phase 
preparative HPLC (Column, C18; mobile phase, water/methanol 99:1 (v/v) for 20 min, 
50:50 for 10 min, and 0:100 for 15 min; UV detector, 254 nm). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Chromatogram of high-purity soybean isoflavones in the analytical reversed-
phase HPLC (Column, C18; mobile phase, water in methanol from 90% to 50% in 40 
min; flow rate of 0.3 mL/min; UV detector, 254 nm): (peak 1) daidzin; (peak 2) glycitin; 
(peak 3) genistin. 
1
2
3
Collected fractions 
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abundant COPs found in fried and roasted salmon were 7-keto and cholestanetriol 
(Echarte et al., 2001). The major pathways of cholesterol oxidation are shown in Figure 
4. Cholesterol could be epoxidized to form 5,6-EP or peroxidized to form 7-OOH that is 
the precursor of 7-OH and 7-keto. Figure 5 is the HPLC chromatogram of cholesterol 
oxidation initiated with AAPH after 24 hr of reaction. Four peaks were found that 
represented four major cholesterol oxidation products: 5,6α-EP, 5,6β-EP, 7-keto, and 7β-
OOH. Cholesterol and its degradation components have shorter retention times than these 
cholesterol oxidation products. Percentage of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 
7-keto, and 7β-OOH accelerated by AAPH at different oxidation times is shown in 
Figure 6. The formation of the four COPs, 5,6α-EP, 5,6β-EP, 7-keto, and 7β-OOH 
occurred quickly and steadily increased within the 48 hr of reaction. However, the 
formation rates were different, with about 21percent of the cholesterol being oxidized to 
7β-OOH from 24hr to 48hr of reaction, while only 7.03, 2.29, and 2.44 percent of 
cholesterol was oxidized to 5,6α-EP, 5,6β-EP and 7-keto respectively from 24hr to 48hr 
of reaction. 
 
                                    (Degradation)                 (Epoxidation) 
 Degradation products                     Cholesterol                      5,6-EP         
 
                                                                    (Free radical chain reactions)       
 
 
                                                           7-OOH 
                                                                                                     
                     
                  (Reduction) 7-OH                                 7-keto (Dehydration) 
                                                  (Dehydrogenation) 
 
 
Figure 4. Major pathways of cholesterol oxidation. 
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Figure 5. Chromatogram of cholesterol oxidation products after 24 hr of oxidation with 5 
mM AAPH and 10 mM cholesterol: (peak 1) 5,6α-EP; (peak 2) 5,6β-EP;  (peak 3) 7-
keto; (peak 4) 7β-OOH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Percentage of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 7-keto, and 7β-OOH 
accelerated by AAPH at different oxidation times: (!) 7β-OOH; (!) 5,6α-EP; (") 7-
keto; (#) 5,6β-EP. 
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4.2.2 Antioxidant Activities of Genistein, Daidzein, and Glycosides Mixture from 
Defatted Soybean Flour 
 
            The structure-activity relationships for antioxidant activities of flavonoids have 
been studied by different groups, with the same conclusion that hydroxyl substitutions on 
the B-ring and the A-ring are the determinants of antioxidant capacity. Hydroxyl 
substitutions on the B-ring especially affect the antioxidant potencies of flavonoids. In 
the case where the B-ring could not contribute to the antioxidant activities of flavonoids, 
hydroxyl substitutions on the A-ring would become a larger determinant of flavonoid 
antioxidant activity (Arora et al., 1998; Silva et al., 2002). The two pharmacophores, the 
4 hydroxyl group on the B-ring and the hydroxyl groups on the AC-ring (Figure 1), 
which could be hydrogen/electron donators to scavenge free radicals, account for soybean 
isoflavones antioxidant activity (Heijnen et al., 2002). Although genistein and daidzein 
have the same B-ring structure, because genistein has one more hydroxyl group than 
daidzein on the AC-ring, genistein might have higher free radical scavenging capacity 
than daidzein. In a cell culture model with HL-60 cells, genistein was revealed to exert 
higher antioxidant activities than daidzein to inhibit TPA-induced H2O2 formation and 
xanthine/xanthine oxidase-caused O2- generation (Wei et al., 1995). Genistein also was 
shown to prevent glucose mediated LDL oxidation more effectively than daidzein (Exner 
et al., 2001). However, this is not always true. Neither genistein nor daidzein had 
influence on LDL oxidation resistance, while both exerted extremely high antioxidant 
activities against LDL oxidation after being esterified (Meng et al., 1999). The authors 
postulated that esterification of soybean isoflavones provided them lipophilicity needed 
for incorporation of soybean isoflavones into LDL. So the similarities between soybean 
isoflavones and chemicals that need protection is of significant importance relative to 
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soybean isoflavones antioxidant activities because the analogous characteristics could 
enable soybean isoflavones to be closer to their target chemicals thus exerting antioxidant 
effects more efficiently. In addition, it has been suggested that an antioxidant mechanism 
other than free radical scavenging reaction may account for soybean isoflavones 
antioxidant effects since they exerted different reactivity to the oxidative stress caused by 
copper or peroxy radicals (Kerry and Abbey, 1998; Hwang, et al., 2000). For example, it 
was found that both free radical scavenging and iron chelating describe flavonoids 
antioxidant activities, although free radical scavenging might play the major role (Acker 
et al., 1996). 
            Figure 7 shows the percentage of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 7-
keto, and 7β-OOH in the genistein, daidzein, or control group after 24 hr or 48 hr of 
reaction. Both genistein and daidzein exhibited very high antioxidant activity because 
each group had significantly less COPs than control group after 24 hr or 48 hr of reaction 
(p<0.05). The percentage of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 7-keto and 7β-
OOH accelerated by AAPH with either 1 mM genistein or 1 mM daidzein treatment after 
24 hr or 48 hr of reaction is listed and compared in Table 2.  Genistein had higher 
antioxidant activities against the formation of 5,6β-EP and 7-keto than daidzein 
(p=0.0007 and p=0.0615 for 5,6β-EP and 7-keto at 24 hr of reaction; p=0.0010 and 
p=0.0019 for 5,6β-EP and 7-keto at 48 hr of reaction). However, the difference between 
genistein and daidzein to inhibit the formation of 5,6α-EP and 7β-OOH was not 
significant (p>0.05). Soybean isoflavones have different affinity to their substrate and 
their antioxidant activities are substrate dependent: the higher the affinity that isoflavones 
have to their substrate, the more efficiently they would exert their antioxidant activities.  
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Figure 7. Percentage of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 7-keto and 7β-OOH 
accelerated by AAPH with or without soybean isoflavone treatment after 24 hr or 48 hr 
of reaction: (bars represent from left to right in each group) control; genistein; daidzein. 
Significant differences in percentage (p< 0.05) are expressed by a different letter at each 
oxidation time. 
 
 
 
 
Table 2. Comparison of percentages of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 7-keto 
and 7β-OOH accelerated by AAPH with either 1 mM genistein or 1 mM daidzein 
treatment after 24 hr or 48 hr of reaction (date were represented as mean ± SD) 
 
                                     Genistein (%)                            Daidzein (%)                      p 
24 hr    5,6α-EP              0.09±0.02                                  0.13±0.04                   0.6297 
            5,6β-EP              0.21±0.03                                   0.44±0.01                   0.0007 
            7-keto                 0.35±0.02                                   0.54±0.03                   0.0615 
            7β-OOH             0.24±0.08                                   0.55±0.12                   0.1654 
48hr     5,6α-EP              0.18±0.01                                   0.39±0.06                   0.4811 
            5,6β-EP              0.33±0.03                                   0.75±0.06                   0.0010 
            7-keto                 0.62±0.13                                   1.05±0.04                   0.0019 
            7β-OOH             0.54±0.03                                   1.62±0.10                   0.2136 
 
 
0
2
4
6
8
10
12
14
24hr                             48hr
pe
rc
en
ta
ge
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
24hr                                48hr
pe
rc
en
ta
ge
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
24hr                             48hr
pe
rc
en
ta
ge
0
5
10
15
20
25
30
35
40
24hr                              48hr
pe
rc
en
ta
ge
(1) 5,6α-EP (2) 5,6β-EP 
(3) 7-keto (4) 7β-OOH 
   a 
     
    
 
           b     b 
 
 
a 
 
 
 
 
 
       b     b 
 
 
  a 
 
 
          b     b 
 
 a 
 
 
 
 
 
 
         b     b 
          
  a 
 
 
                 c 
         b 
 
   a 
 
 
 
               c 
         
        b 
   a 
 
                 c 
          b 
 
 
 
a 
 
 
               c 
        b  
  37    
For example, genistein was found to have higher affinity to liposomal membrane than 
daidzein and aglycones had higher affinity to liposomal membrane than glycosides 
(Murota et al., 2002). According to Sigma production information, daidzein has higher 
lipophility than genistein (daidzein has one less hydroxyl group than genistein), so 
daidzein might have greater ability to associate with cholesterol in the small droplets of 
the emulsion. Thus daidzein could exert its antioxidant activity more efficiently than 
genistein, which would compensate for the fact that daidzein has lower radical quenching 
capacity and explain the similar antioxidant activity between genistein and daidzein 
against cholesterol oxidation to 5,6α-EP and 7β-OOH. 
            As with the formation of different COPs under different conditions, the formation 
of COPs might have different susceptibility to certain antioxidants. For example, the 
formation of 7-keto was retarded by BHA, BHT, and a-tocopherol markedly, but the 
formation of 7α-OH and 7β-OH was reduced to a lesser degree (Csallany et al., 2002). 
The percentages of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 7-keto, or 7β-OOH 
accelerated by AAPH with or without soybean isoflavone treatment at different reaction 
times are shown in Figure 8. The rates for the formation of 7β-OOH, 7-keto, 5,6α-EP, 
and 5,6β-EP were calculated as the slopes of the lines. They all decreased dramatically 
with either genistein or daidzein treatment compared to control (Table 3). Both genistein 
and daidzein had significantly stronger inhibition to the formation of 7β-OOH than to 7-
keto. 7β-OOH, which could be dehydrated to 7-keto, is the precursor of 7-keto in the 
cholesterol oxidation reaction initiated by free radicals (Figure 3), so soybean isoflavones 
might have stronger inhibition to peroxidation of cholesterol, the former step of chain 
reaction, than to dehydration, the later step of the chain reaction. The formation of 5,6α- 
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Figure 8.  Percentage of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 7-keto, and 7β-OOH 
accelerated by AAPH with or without soybean isoflavone treatment at different reaction 
times: (!) control; (") daidzein; (#) genistein. 
 
 
 
Table 3. Percentage of formation rates for 7β-OOH, 7-keto, 5,6α-EP, and 5,6β-EP 
decreased by either genistein or daidzein treatment compared to control (unit for 
formation rate: percentages per hour) 
 
                                7β-OOH                                                  7-keto     
Treatment   Formation rate   Decreased percentage          Rate      Decreased percentage     
Genistein         0.0254                    97.24%                      0.0273            64.91%                 
Daidzein          0.0498                    91.06%                      0.0397            48.97%                 
Control            0.5570                                                       0.0778  
                                5,6α-EP                                                  5,6β-EP 
Treatment   Formation rate   Decreased percentage         Rate      Decreased percentage 
Genistein         0.0065                    96.02%                      0.0154             82.32% 
Daidzein          0.0093                    94.30%                      0.0324             62.80% 
Control            0.1632                                                       0.0871 
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EP and 5,6β-EP are usually investigated together because they have nearly the same 
formation pathway. The formation of 5,6α-EP and 5,6β-EP were studied separately in 
this study and the inhibition to the formation of 5,6α-EP by either genistein or daidzein 
treatment was much stronger than to 5,6β-EP, which could arise from differences in 
stability between 5,6α-EP and 5,6β-EP, or favorable chiral structure of genistein and 
daidzein to 5,6α-EP. 7β-OOH had a much higher formation rate than 7-keto and the 
formation rate of 5,6α-EP was also higher than that of 5,6β-EP, so the inhibition by 
soybean isoflavone might be related to the formation rate of COPs: the higher the 
formation rate, the stronger the inhibition from soybean isoflavones. These results 
suggest that different biomarkers should be used in the study of cholesterol oxidation 
under different conditions and more than one biomarker should be used to study the 
antioxidant activity of compounds of interest when using a cholesterol oxidation model. 
            The percentages of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 7-keto, and 7β-
OOH accelerated by AAPH with or without glycosides mixture treatment at different 
reaction times are shown in Figure 9. The formation rate calculated as the slope of the 
lines for each COPs is shown in Table 4. In a manner similar to geinistein and daidzein, 
the glycosides mixture had much stronger inhibition to the formation of 7β-OOH than to 
7-keto and had stronger inhibition to the formation of 5,6α-EP than to 5,6β-EP. In order 
to compare the antioxidant activities between aglycones and the glycosides mixture, it 
was assumed that antioxidant activity would be linear within the molar concentration 
range used in this study. Although genistein, daidzein, and the glycosides mixture had 
different molar concentrations in the reaction system, according to this assumption, their 
antioxidant activities could be compared relative to molar concentration and the results  
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Figure 9.  Percentage of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 7-keto, and 7β-OOH 
accelerated by AAPH with or without glycosides mixture treatment at different reaction 
times: (!) control; (!) glycosides mixture. 
 
 
 
 
 
Table 4. Percentage of formation rates for 7β-OOH, 7-keto, 5,6α-EP, and 5,6β-EP as 
affected by glycosides mixture compared to control (unit for formation rate: percentages 
per hour) 
 
                                7β-OOH                                                  7-keto     
Treatment   Formation rate   Decreased percentage          Rate      Decreased percentage     
Mixture           0.1872                    66.39%                       0.0657            15.55% 
Control            0.5570                                                       0.0778 
                                5,6α-EP                                                  5,6β-EP 
Treatment   Formation rate   Decreased percentage         Rate      Decreased percentage 
Mixture           0.0330                    79.78%                       0.0615             29.39%  
Control            0.1632                                                       0.0871 
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are shown in Table 5. The glycosides mixture had lower antioxidant activities than the 
aglycones, genistein and daidzein (p<0.05), which might arise from the fact that 
glycosides have one less hydroxyl group because of the binding of glucose. As the 
aglycones have higher affinity to liposomal membrane than glycosides (Murota et al., 
2002), aglycones might also have higher affinity to cholesterol droplets than glycosides 
because of their higher lipophilicity, so alycones would exert antioxidant activities 
against cholesterol oxidation more efficiently than glycosides. Also, the glycosides 
mixture is composed of genistin and daidzin, together with glycitin that might have lower 
antioxidant activity because of its methoxyl substitution instead of hydroxyl substitution 
on the B-ring (Figure 1) (Arora et al., 1998). The study of the different antioxidant 
activities between glycosides and aglycones would be mute for in vivo study because 
most of the glycosides would be converted to aglycones by intestinal microorganisms 
during absorption (Adlercreutz, 1995). However, this could have significance in vitro.  
For example, it may be beneficial to treat the soy products in a way that would convert 
glucosides to aglycone forms in order to increase antioxidant capacity.  
Table 5. Comparison of percentages of cholesterol oxidized to 5,6α-EP, 5,6β-EP, 7-keto 
and 7β-OOH accelerated by AAPH with 1 mM different soybean isoflavone treatment 
after 24 hr or 48 hr of reaction (date were represented as mean ± SD) 
 
                              Genistein (%)        Daidzein (%)     Glycosides mixture (%)           p 
24 hr    5,6α-EP        0.09±0.02             0.13±0.04                 0.34±0.06                   0.0009 
            5,6β-EP         0.21±0.03             0.44±0.01                0.60±0.06                  <0.0001 
            7-keto            0.35±0.02             0.54±0.03                0.64±0.14                   0.0120 
            7β-OOH        0.24±0.08             0.55±0.12                1.58±0.27                   0.0002 
48hr     5,6α-EP         0.18±0.01             0.39±0.06                1.69±0.36                   0.0002 
            5,6β-EP         0.33±0.03             1.75±0.06                1.09±0.10                  <0.0001 
            7-keto            0.62±0.13             1.05±0.04                1.25±0.06                    0.0003 
            7β-OOH        0.54±0.03             1.62±0.10                7.09±1.19                  <0.0001 
 
  42    
4.3 Antioxidant Activities of Soybean Isoflavones on tert-Butyl Hydroperoxide-
Induced Oxidative Stress in SVEC4-10 Cells 
 
4.3.1 Growth Curve of SVEC4-10 Cells 
            SVEC4-10 is an endothelial cell line derived by SV40 transformation of 
endothelial cells from mouse auxiliary lymph node vessels. They have epithelial 
morphology and form branching tube-like networks when adhering and growing on the 
surface of culture plates. The growth curve of SVEC4-10 cells was a sigmoidal line 
(Figure 10). Cells grew slowly when the density was below 2×105 cell/cm2 and then 
divided and grew very fast from the density of 2×105 cells/cm2 to 5×105 cells/cm2. After 
that, the growth of SVEC-4-10 reached a plateau because the growth area had been 
occupied completely. In order to decrease variance, the plated density of 2×105 cells/cm2 
was applied in each experiment so the density on the third day would be within the lag 
phase of growth. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. The growth curve of SVEC-4-10 cells with the plated cell density of 8.7×104 
cell/cm2 
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4.3.2 Cytotoxicity of Genistein and Daidzein 
            According to pharmaceutical studies, plasma concentration of soybean 
isoflavones could range from 0.55 mM to 0.86 mM after two weeks administration of soy 
beverage (Barnes et al., 1996). However, in this study, the concentration that did not alter 
the viability of SVEC4-10 cells over a 24 hr incubation compared to control cells only 
ranged from 0 µM to 1 µM. Both genistein and daidzein caused cell viability to decrease 
in a dose dependent manner when the concentration reached above 1 µM (Figure 11).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Effect of soybean isoflavones on the viability of SVEC4-10 cells over a 
concentration ranging from 0 µM to 50 µM for 24 hrs (cell viability was expressed by 
percentage of total cellular activity): (#) daidzein; (!) genistein. 
 
 
 
            Genistein caused a more severe decrease in cell viability than daidzein at the same 
concentration. Cell viabilities after 24 hr of genistein or daidzein treatment are listed and 
compared in Table 6. Only at the concentrations of 2.5 µM and 5 µM was there no 
significant difference between the genistein and daidzeins cytotoxicity (p=0.2105 for 2.5 
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µM and 0.0782 for 5 µM). Significant differences were found when the concentrations 
were above 5 µM.  For example, at 50 µM, daidzein treatment maintained 88.73 ± 
12.11% of cell viability, while genistein treatment maintained only half of the cell 
viability compared to control. At 100 µM, daidzein treatment maintained 83.10 ± 7.62% 
of cell viability, while genistein treatment caused the cell viability to decrease to 9.73 ± 
8.91%. Obviously, genistein had a higher cytotoxicity than daidzein to SVEC4-10 cells. 
The anti-proliferation action of soybean isoflavones has been studied with a number of 
cancer cell lines and many mechanisms have been postulated, such as modulation of 
estrogen receptor signal and inhibition of tyrosine kinase. However, in a test with yeast 
estrogen screening, only genistein was found to induce an estrogen signal, while no 
signal was detected for either daidzein or glycitein (De-Boever and Verstraete, 2000). 
SVEC4-10 cells have characteristics similar to cancer cells because they could grow 
indefinitely without special addictives. After a latency period of 14 weeks, they would 
induce spindle tumors with some of the histo-pathologic characteristics of human Kaposi 
Sarcoma (OConnell et al., 1991).            
 
Table 6. Comparison of cell viabilities after different concentrations of genistein or 
daidzein treatment (data were represented as mean ± SE; probability of p<0.05 was 
considered statistically significant) 
 
Concentration (µM)                2.5                     5                       10                       25                      
Genistein (viability %)   94.69±5.09       80.34±11.00      66.64±13.81        56.55±9.62 
Daidzein (viability %)    99.11±0.79       96.42±4.37        96.19±3.57          92.59±7.26       
       P                                 0.2105               0.0782                0.0230                0.0066              
Concentration (µM)                50                    100       
Genistein (viability %)   46.52±10.07        9.73±8.91 
Daidzein (viability %)    88.73±12.11       83.10±7.62 
       P                                 0.0097                0.0004 
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            In order to avoid any possible cytotoxic effects, the concentration of 1 µM, where 
daidzein treatment maintained 100± 0% of cell viability and genistein treatment 
maintained 99.2 ± 1.39%, was chosen to test their antioxidant activity in cells. 
4.3.3 Cytotoxicity of tBOOH 
            Oxidative stress induced by tBOOH could cause DNA damage and membrane 
integrity loss, ultimately leading to cell death. Figure 12 shows the effect of tBOOH 
ranging from 100 µM to 500 µM on cell viability of SVEC4-10 cells. A dose-dependent 
effect was evident. At 100 µM, tBOOH caused the cell viability to decrease to 73.01 ± 
15.38% of the control after 5 hr of incubation. A similar decrease was obtained after 3 hr 
of incubation with 250 µM tBOOH and after 2 hr with 500 µM tBOOH. On the basis of 
this result, to investigate the antioxidant activity of soybean isoflavones, a concentration 
of 500 µM was chosen in order to induce a substantial oxidative stress and cause the cell 
viability to decrease substantially compared to control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Decreased viability of SVEC4-10 cells in response to increasing concentration 
of tBOOH (cell viability was expressed by percentage of total cellular activity): (!) 0 
µM; (#) 100 µM; (") 250 µM; (!) 500 µM. 
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4.3.4 Antioxidant Activities of Genistein and Daidzein 
            After being absorbed, soybean isoflavones would either circulate in the blood 
steam or be incorporated into tissues. Circulating soybean isoflavones might offer 
protective activity as much as incorporated isoflavones, however, almost all of the 
previous research that has been done in this area used incorporated isoflavones to study 
soybean isoflaovnes antioxidant activities in vivo or in vitro. In order to elucidate how 
soybean isoflavones exert their antioxidant activity in vivo, two approaches were used 
here to investigate the protective activity of genistein and daidzein against tBOOH 
induced oxidative stress in SVEC4-10 endothelial cells. In the first approach (method A), 
soybean isoflavones were added into the cell culture media together with tBOOH at the 
same time, which simulated the circulating isoflavones because soybean isoflavones had 
not been incorporated into SVEC4-10 cells before tBOOH treatment. The result is shown 
in Figure 13. Different from what had been expected, no significant difference was found 
between the cell viability of control group and that of experimental groups within 5 hr of 
tBOOH treatment. In the second approach (method B), which was designed to simulate 
the incorporated soybean isoflavones, cells were incubated with soybean isoflavone 
solution for 24 hrs and the non-attached genistein and daidzein was washed away before 
the cell was treated with tBOOH. Thus, only incorporated soybean isoflavones would be 
in this experimental model. The results are shown in Figure 14. As with the results from 
method A, no significant difference was found between the cell viability of control group 
and that of experimental groups. 
            The results demonstrated that soybean isoflavones, whether incorporated or non-
incorporated, did not exert enough antioxidant activities against tBOOH induced  
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Figure 13. Cellular viability after soybean isoflavone treatment against oxidative stress 
caused by tBOOH on SVEC4-10 cells (method A) (cell viability was expressed by 
percentage of total cellular activity): (!) genistein; (#) daidzein; (") control.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Cellular viability after soybean isoflavone treatment against oxidative stress 
caused by tBOOH on SVEC4-10 cells (method B) (cell viability was expressed by 
percentage of total cellular activity): (!) genistein; (#) daidzein; (") control. 
 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5
Time (hr)
Pe
rc
en
ta
ge
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5
Time (hr)
Pe
rc
en
ta
ge
  48    
oxidative stress in SVEC4-10 cells. The reason might be that the concentration of 1 µM 
was too low for soybean isoflavones to exhibit any discernable antioxidant activities in 
method A. The incorporation of soybean isoflavones into LDL has been studied and the 
incorporation ratio was very low (approximately 3-4%), so copper-mediated oxidation of 
control LDL and LDL isolated from plasma pre-incubated with genistein was not 
significantly different (Kerry and Abbey, 1998). Tikkanen et al., (1998) examined the 
different oxidation resistances between control LDL and LDL pre-incubated with 
soybean isoflavones but suggested that it was not soybean isoflavones antioxidant 
activities directly but modified LDL that was produced by circulating isoflavones that 
promoted the oxidation resistance of LDL. In this research, the incorporation ratio of 
soybean isoflavones into cells might be very low due to the low concentration of 1 µM 
and the limited incubation time of 24 hr may have limited the potential antioxidant 
activity of soybean isoflavones in method B. 
            Soybean isoflavones have also been reported to promote endogenous antioxidant 
enzymes, by which they exhibit their special antioxidant activity, but the limited 
incubation time in our research decreased the possible influence that soybean isoflavones 
might exhibit on the antioxidant system of cells. Moreover, the toxic effects that 
originated from tBOOH may include S-thiolation of some key proteins thus inhibiting 
protein synthesis (Latour, et al., 1999), the effects of which could not be recovered by 
any antioxidant activity alone. These reasons help to explain why treatments had the 
same cell viabilities as controls in this research. Therefore, some modifications are 
needed in order to improve this cell culture model, such as increasing the treatment 
concentration, increasing the treatment duration, or changing the oxidative stress initiator. 
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Perhaps of even greater importance could be that this cell culture model is not suitable for 
the study of antioxidant activities, but it might be applied to the study of anti-caner 
activities of soybean isoflavones that is becoming a more and more popular research area. 
            The cell viabilities of the 500 µM group (C group) in tBOOH cytotoxicity study 
and the two control groups in method A (A group) and method B (B group) are listed in 
Table 5. All three of these groups used 500 µM tBOOH treatment, but both A and B 
groups had higher cell viability than C at the same treatment time. The only difference 
among these groups was that there was 0.7% of dimethyl sulfoxide (DMSO) in A and B 
groups but not in the C group. The cell viability difference might come from DMSO that 
exerted some antioxidant activity against tBOOH induced oxidative stress, and thus 
increased the cell viabilities in both A and B groups compared to C group.  
 
 
Table 7. Comparison of cell viabilities of the 500 µM group (C group) in cytotoxicity 
study of tBOOH and the control groups in method A (A group) and method B (B group) 
 
Group/Time (hr)         1                    2                     3                     4                     5 
        A (%)        90.58±2.40    84.84±5.84     79.88±6.60     73.84±8.80    64.86±7.94  
        B (%)        93.3±8.15      91.53±8.61      89.12±8.79     84.81±6.47   79.35±9.46 
        C (%)        84.66±8.09   71.08±13.03    64.09±11.79   58.75±14.47  52.14±18.27 
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Chapter 5 
Conclusion 
 
            Soybean isoflavones, including genistein, daidzein, and glycitein and their 
derivatives, exist mainly in the glycoside form in the soybean. In order to prevent any 
possible enzymatic hydrolysis that may break down the glycoside groups, methanol was 
used as solvent to extract soybean isoflavones from defatted soy flour. A reversed phase 
HPLC method was developed and used to purify soybean isoflavone extract and the 
purity of the final product reached 94% based on an analytical HPLC analysis. 
            Genistein might have higher antioxidant activities than daidzein because it has the 
same B-ring structure as daidzein yet has one more hydroxyl group on the AC-ring. No 
significant difference was found between the antioxidant activities of daidzein and 
genistein against cholesterol oxidation to 5,6α-EP and 7β-OOH, although genistein 
exerted higher inhibition to the formation of 5,6β-EP and 7-keto than daidzein. The 
substrate dependent characteristic of soybean isoflavones helps to explain the above 
result. Because daidzein has higher lipophilicity than genistein (daidzein has one less 
hydroxyl group than genistein), daidzein might have greater ability to associate with 
cholesterol in the small droplets of the emulsion, thus exerting antioxidant activity more 
efficiently than genistein, which could compensate for daidzeins lower radical 
quenching capacity. The cholesterol oxidation model results also indicated that 
isoflavone aglycones might have higher antioxidant activities than their glycosides. This 
would not be important in vivo since most of the glycosides would be cleaved to form 
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aglycones by intestinal microorganisms during their absorption in the GI system but 
could have significance in cholesterol containing foods. 
            Cholesterol could be oxidized to form different COPs under different conditions 
and the formation of COPs might have different susceptibility to certain antioxidants. In 
this cholesterol oxidation model, all three treatments, genistein, daidzein, and the 
glycosides mixture, had higher inhibition to the formation of 7β-OOH than to 7-keto and 
had higher inhibition to the formation of 5,6α-EP than to 5,6β-EP. This suggests that 
different biomarkers should be used in the study of cholesterol oxidation under different 
conditions and more than one biomarker should be used when using a cholesterol 
oxidation model to study antioxidant activity. 
            Genistein had much higher cytotoxicity than daidzein to SVEC4-10 cells. In order 
to compare the antioxidant activities of genistein and daidzein at the same level, the 
concentration of 1 µM was selected. However, contrary to what had been expected, no 
significant difference was found between the cell viability of control group and that of 
experimental groups treated with either genistein or daidzein in both methods. This 
implies that neither genistein nor daidzein exerted discernable antioxidant activities 
against oxidative stress induced by tBOOH in SVEC4-10 cells. The reasons may be the 
low concentration of 1 µM and the limited incubation time of 24 hr, or could be due to 
the inhibition of protein synthesis caused by tBOOH that could not be overcome by 
antioxidant. Therefore, some modifications are needed in order to improve the cell 
culture model, such as increasing the treatment concentration, increasing the treatment 
duration, or changing the oxidative stress initiator. Also, perhaps the cell culture model is 
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not suitable for antioxidant activities study, but might be utilized in the study of anti-
caner activity of soybean isoflavones, which is becoming a popular research area. 
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